- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Potentially Undervalued Companies
Global Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
2036
Companies with a Value score of at least 3, ordered by Value score
2036 companies
Spectrum Pharmaceuticals
Market Cap: €209.9m
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products.
NTR
€0.93
7D
0.5%
1Y
11.6%
Trajan Group Holdings
Market Cap: AU$99.2m
Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.
TRJ
AU$0.66
7D
4.0%
1Y
-32.8%
Zevra Therapeutics
Market Cap: US$484.2m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$8.60
7D
-6.3%
1Y
-9.4%
Grand Pharmaceutical Group
Market Cap: €28.4b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
MX6A
€0.88
7D
-4.4%
1Y
73.3%
Hikma Pharmaceuticals
Market Cap: €3.5b
Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.
H5P
€18.30
7D
3.4%
1Y
-22.5%
Tianjin Ringpu Bio-TechnologyLtd
Market Cap: CN¥8.9b
Engages in the research and development, production, and sale of veterinary raw materials, drug preparation, functional additives, and veterinary biological products.
300119
CN¥19.56
7D
-5.1%
1Y
6.9%
Apeloa PharmaceuticalLtd
Market Cap: CN¥18.2b
Provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally.
000739
CN¥15.83
7D
2.3%
1Y
1.5%
Jiang Zhong PharmaceuticalLtd
Market Cap: CN¥13.6b
Engages in the manufacture of pharmaceutical products in China.
600750
CN¥21.61
7D
-1.4%
1Y
6.9%
Tonghua Dongbao Pharmaceutical
Market Cap: CN¥16.6b
Researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China.
600867
CN¥8.56
7D
-5.1%
1Y
2.4%
Sanofi
Market Cap: €104.6b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
1SAN
€86.30
7D
-4.1%
1Y
-6.6%
Sanofi
Market Cap: €104.6b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SNW
€86.07
7D
-3.3%
1Y
-7.2%
Curaleaf Holdings
Market Cap: US$2.3b
Produces and distributes cannabis products in the United States and internationally.
CURL.F
US$2.15
7D
7.3%
1Y
8.9%
Amphastar Pharmaceuticals
Market Cap: US$1.2b
A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
AMPH
US$26.44
7D
1.6%
1Y
-40.8%
Prestige Consumer Healthcare
Market Cap: €2.9b
Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
PBV
€50.50
7D
1.0%
1Y
-37.7%
CSL
Market Cap: AU$88.3b
Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.
CSL
AU$183.46
7D
1.4%
1Y
-34.7%
WuXi AppTec
Market Cap: CN¥280.3b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥93.97
7D
0.2%
1Y
91.4%
Tianjin Ringpu Bio-TechnologyLtd
Market Cap: CN¥8.9b
Engages in the research and development, production, and sale of veterinary raw materials, drug preparation, functional additives, and veterinary biological products.
300119
CN¥19.56
7D
-5.1%
1Y
6.9%
Consun Pharmaceutical Group
Market Cap: HK$12.8b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$15.13
7D
2.0%
1Y
76.5%
Sanofi
Market Cap: €104.6b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
0O59
€86.33
7D
-4.0%
1Y
-6.8%
Zoetis
Market Cap: €53.8b
Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.
ZOE
€106.04
7D
3.6%
1Y
-37.6%
Sanofi
Market Cap: €104.6b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SAN
€85.95
7D
-4.4%
1Y
-7.4%
Sanofi
Market Cap: €104.6b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SANP
€86.16
7D
-3.5%
1Y
-5.2%
Hikma Pharmaceuticals
Market Cap: UK£3.6b
Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.
HIK
UK£16.09
7D
2.0%
1Y
-18.7%
Catalyst Pharmaceuticals
Market Cap: US$2.9b
A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
CPRX
US$23.42
7D
3.8%
1Y
10.5%
Supernus Pharmaceuticals
Market Cap: US$2.6b
A biopharmaceutical company, develops and commercializes products for the treatment of central nervous system (CNS) diseases in the United States.
SUPN
US$45.32
7D
0.5%
1Y
25.5%
Genomma Lab Internacional. de
Market Cap: €17.3b
Provides pharmaceutical and personal care products primarily in Mexico and internationally.
GEKA
€0.81
7D
0.6%
1Y
-32.5%
Yunnan Baiyao GroupLtd
Market Cap: CN¥99.3b
Engages in the pharmaceutical business in China.
000538
CN¥55.65
7D
-1.2%
1Y
-2.4%
Dong-A Socio Holdings
Market Cap: ₩709.2b
Engages in the pharmaceutical business in South Korea.
A000640
₩110,200.00
7D
2.3%
1Y
8.8%
CSL
Market Cap: AU$88.3b
Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.
CSL
AU$182.95
7D
1.4%
1Y
-34.9%
Hugel
Market Cap: ₩2.4t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩221,000.00
7D
-6.0%
1Y
-16.6%
Apeloa PharmaceuticalLtd
Market Cap: CN¥18.2b
Provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally.
000739
CN¥15.83
7D
2.3%
1Y
1.5%
Sanofi
Market Cap: €104.6b
Engages in the research, development, manufacture, and marketing of therapeutic solutions.
SNW
€86.20
7D
-4.3%
1Y
-6.8%
Zoetis
Market Cap: €53.8b
Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.
ZOE
€106.12
7D
2.7%
1Y
-37.2%
Cosmo Pharmaceuticals
Market Cap: €1.1b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
C43
€72.00
7D
2.9%
1Y
10.8%
China Resources Pharmaceutical Group
Market Cap: €29.8b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
640
€0.52
7D
-3.7%
1Y
-16.8%
Gedeon Richter
Market Cap: €1.8t
Researches, develops, manufactures, markets, and sells pharmaceutical products.
RIG2
€25.06
7D
0.2%
1Y
-5.4%